I

Intellia Therapeutics

CRISPR-Cas9 genome-editing therapeutics developer

Vice President, Gene Editing Core

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timeCambridge, MA, USAIn-person

About the Job

Requirements

  • Extensive experience in genomics, including sequencing technologies and genomic data analysis.
  • Familiarity with industry regulations and standards, including compliance requirements related to genomic research and data management.
  • Experience with genomic technologies including next-generation sequencing, droplet digital polymerase chain reaction, single-cell genomics, and spatial transcriptomics.
  • A strong foundation in experimental design and bioinformatics, including the ability to design experiments, analyze data, and interpret results.
  • Proven experience leading a team of core-function scientists, managing multiple projects simultaneously, leading projects, and overseeing laboratory operations.
  • Familiarity with relevant regulatory standards and guidelines.
  • Ability to analyze complex problems, identify solutions, and implement them effectively.
  • Deep understanding of the relevant industry and its trends, including preclinical and clinical research.
  • Ability to prioritize multiple tasks and projects in a fast-paced environment.
  • A PhD or equivalent in a relevant field such as molecular biology, biochemistry, or genomics; candidates with a PhD require at least 8 years of related professional experience, while candidates with a master's or bachelor's degree require at least 10 years of relevant experience.
  • At least 7 years of experience directly managing people.

Responsibilities

  • Create and lead the vision for genomics innovation supporting research to develop gene-editing therapies.
  • Collaborate across Platform Innovation and Delivery Innovation to advance novel nucleases, insertion strategies, technologies, delivery advancements, and assays assessing potential unintended genomic changes.
  • Support screening efforts by generating data for pipeline programs and platform improvements, including guide RNA, messenger RNA, delivery optimization, and novel nuclease advancement.
  • Oversee next-generation sequencing production efforts, including AMP-seq, off-target discovery and confirmation, and structural variant analysis.
  • Collaborate with Pre-Clinical next-generation sequencing for assay transfer, validation, and scale-up.
  • Partner with computational biology, software engineering, and automation teams on data analysis, data capture, and workflow optimization.
  • Evaluate and adopt technologies and platforms that improve methods and support the company's strategic direction.
  • Oversee the Genomics Core budget and resource allocation, including equipment purchases, and ensure timely service delivery across company projects.
  • Ensure proper documentation and sample tracking, and compliance with regulations, guidelines, and standards for genomic research, data management, and biosafety.
  • Communicate with users, provide guidance, and engage external consultants and collaborators as needed.
  • Work with clinical, regulatory, and product development teams to integrate gene-editing and genomics insights into workflows and business processes.
  • Represent the function on program teams, providing expertise and guidance on gene-editing methods to support development-candidate nomination and regulatory filings.
  • Foster collaboration, innovation, teamwork, and communication, and handle employee discipline and termination in accordance with company policy.
  • Provide strategic direction and oversight to the Computational Biology team and ensure efficient daily operations.
  • Lead, mentor, and develop scientists; oversee daily workflows of the Gene Editing Core teams; and manage hiring, training, staff assignment, coaching, mentoring, and performance management.
  • Promote open communication, transparency, cross-functional teamwork, knowledge sharing, continuous learning, and professional growth.
  • Ensure adherence to company policies and procedures, address performance issues, and implement corrective actions as needed.

About the Company

Intellia Therapeutics

CRISPR-Cas9 genome-editing therapeutics developer

Intellia Therapeutics develops CRISPR-Cas9 genome editing therapies to treat severe genetic diseases. Its work centers on using CRISPR to edit genes and delivering the editing tools to the right cells with a modular lipid nanoparticle system, aiming to create treatments that can be given to patients and move through clinical trials toward market. The company earns revenue through R&D collaborations, licensing, and potential sales of approved therapies. Compared to others in biotech, Intellia emphasizes in vivo gene editing using a distinctive lipid nanoparticle delivery approach and active partnerships to advance candidates. Its goal is to bring safe, effective genome-editing treatments to patients while building value through collaborations and licensing.

Company size
501-1,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Intellia Therapeutics

See more jobs